Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




ASCO 2009: Antidote for 5-FU Overdose Appears Highly Effective
Link ID 16666
Title ASCO 2009: Antidote for 5-FU Overdose Appears Highly Effective
Url http://www.medscape.com/viewarticle/704491?src=rss
Description A poster presentation indicates that a new drug, vistonuridine, is an effective antidote for 5-FU overdose, even when the expected outcome was death. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Jun 18, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Harry Messmore, MD, Receives Legion of Honor Award From France
  Dr. Messmore, a pioneer in hematologic research and anticoagulation therapy, has received a belated tribute from France for HIS heroism during World War II. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Survival of Elderly Lung Cancer Patients Improved With SABRSurvival of Elderly Lung Cancer Patients
  The survival of all elderly patients with nonsmall-cell lung cancer increased significantly after the introduction of stereotactic ablative radiotherapy (SABR). br / iMedscape Medical News/i
Category:   Articles > Hematology-Oncology


3. Overall Survival: All the News Fit to PrintOverall Survival: All the News Fit to Print
  Dr. Kathy Miller comments on early reports that a phase 3 trial of T-DM1 shows "substantially" increased survival in HER2-positive breast cancer patients. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


4. ESMO Wrap-up: The Global Village That Is Oncology
  ESMO President Dr. David J. Kerr hails the rise of European and Asian oncology and sees cooperation between international oncologists as the key to understanding cancer. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


5. Triple-negative Breast Cancer: Disease Entity or Title of Convenience?
  New systemic therapies are urgently needed for triple-negative breast cancer tumors because hormonal therapies and HER2-targeted agents are ineffective. Nature Reviews Clinical Oncology
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS